Metropolitan Life Insurance Company (MetLife)’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,160
Closed -$91K 2602
2020
Q4
$91K Buy
3,160
+55
+2% +$1.49K ﹤0.01% 2398
2020
Q3
$92.5K Buy
+3,105
New +$94.3K ﹤0.01% 2261

Other funds holding AFIB

Metropolitan Life Insurance Company (MetLife)'s AFIB Position: Q1 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Acutus Medical Inc (AFIB) in Q1 2021, closing a stake of 3,160 shares — an estimated $91K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AFIB in Q3 2020 and held it in 2 quarters. The position peaked at $92.5K in Q3 2020. 67 funds tracked by Wall St. Rank hold AFIB as of Q1 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Acutus Medical Inc position as of Q1 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,160 Acutus Medical Inc shares in Q1 2021, an estimated $91K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Acutus Medical Inc in Q3 2020 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Acutus Medical Inc position peaked at $92.5K in Q3 2020.
  • 67 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2021, filed 14 May 2021.